Xylazine was discovered as an antihypertensive agent in 1962 by Farbenfabriken Bayer in Germany. Due to its hazardous side effects, including sedation, hypotension and bradycardia, it was not approved by…
READ MORE
MDMB-4en-PINACA was first identified in toxicology casework in the United States in September 2019; however, its emergence dates back earlier to seized drug testing from Europe in June 2018. MDMB-4en-PINACA…
READ MORE
Levamisole was initially developed in the mid-1960s as a veterinary and human anti-worming drug. In 1990, it was approved by the United States Food and Drug Administration (FDA) as a…
READ MORE
Brorphine is a potent synthetic opioid with structural resemblance to fentanyl and its analogues. However, brorphine is not controlled in the U.S. under core-structure scheduling of fentanyl related substances. Recent…
READ MORE
Between 2017 and 2019, the substituted cathinone N-ethyl pentylone (ephylone) was the most commonly encountered emergent synthetic stimulant to appear in forensic casework. Due to its prevalence and contributions to…
READ MORE
Flualprazolam has been confirmed in at least 44 biological specimens associated with postmortem (PM) death investigations and driving under the influence of drugs (DUID) investigations in the United States since…
READ MORE
Isotonitazene has been identified in eight blood specimens associated with postmortem death investigations in the United States since August 2019. Isotonitazene was first reported in August 2019 based on the…
READ MORE
The objective of this public announcement is to notify public health and public safety, law enforcement, clinicians, medical examiners and coroner, laboratory personnel, and all other related communities about new…
READ MORE
The Center for Forensic Science Research and Education at the Fredric Rieders Family Foundation received notification over the weekend from July 20 to 22, 2018, that hospitals in the Greater…
READ MORE